NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife announced a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.84%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife declared that its Board of Directors has authorized a share buyback program on Tuesday, May 22nd 2018, which permits the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board of directors believes its stock is undervalued.

Metlife Inc (NYSE:MET) issued its quarterly earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 EPS for the quarter, beating the Zacks' consensus estimate of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to the consensus estimate of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The firm's revenue was up .6% compared to the same quarter last year. During the same period last year, the business posted $1.20 EPS. View Metlife's Earnings History.

17 brokerages have issued 12-month target prices for Metlife's stock. Their predictions range from $47.00 to $78.00. On average, they anticipate Metlife's share price to reach $56.60 in the next year. This suggests a possible upside of 29.3% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a decline in short interest in the month of June. As of June 29th, there was short interest totalling 12,020,672 shares, a decline of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily trading volume, of 7,086,353 shares, the days-to-cover ratio is presently 1.7 days. Currently, 1.4% of the shares of the company are short sold. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

News headlines about MET stock have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Metlife earned a coverage optimism score of 0.07 on Accern's scale. They also gave press coverage about the financial services provider an impact score of 47.13 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Metlife's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), RNC Capital Management LLC (0.08%), Retirement Systems of Alabama (0.06%) and Cambiar Investors LLC (0.05%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Calamos Advisors LLC, Channing Capital Management LLC, Hartford Investment Management Co., Welch & Forbes LLC, Gofen & Glossberg LLC IL, Cambiar Investors LLC and Jolley Asset Management LLC. View Insider Buying and Selling for Metlife.

MET stock was purchased by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Cornerstone Wealth Management LLC, Capital One National Association, Retirement Systems of Alabama, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V. and Addenda Capital Inc.. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $43.76.

Metlife has a market capitalization of $44.48 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.